Clinical Trial Update: PF-06372865 in Subjects With Photosensitive Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial update for PF-06372865 in subjects with photosensitive reflex epilepsy; the study has completed with results posted in March 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy
• Reflex Epilepsy

Drugs mentioned

• PF-06372865

Snippet

Sponsor: Pfizer | Conditions: Reflex Epilepsy, Photosensitive | Phase 2 | Status: COMPLETED | Results posted: 2018-03-14